You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 10,023,560


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,023,560 protect, and when does it expire?

Patent 10,023,560 protects QUVIVIQ and is included in one NDA.

This patent has thirty-seven patent family members in thirty-two countries.

Summary for Patent: 10,023,560
Title:Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-meth- oxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
Abstract: The invention relates to a crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-- yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone hydrochloride, processes for the preparation thereof, pharmaceutical compositions containing said crystalline form, and its use as medicament, especially as orexin receptor antagonist.
Inventor(s): Boss; Christoph (Allschwil, CH), Brotschi; Christine (Allschwil, CH), Gude; Markus (Allschwil, CH), Heidmann; Bibia (Allschwil, CH), Sifferlen; Thierry (Allschwil, CH), Von Raumer; Markus (Allschwil, CH), Williams; Jodi T. (Allschwil, CH)
Assignee: IDORSIA PHARMACEUTICALS LTD (Allschwil, CH)
Application Number:15/702,281
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

United States Patent 10,023,560: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 10,023,560 is a significant intellectual property asset in the pharmaceutical sector, particularly related to the manufacture and use of certain active ingredients. This article delves into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

Patent Number and Title

The patent in question is U.S. Patent No. 10,023,560. While the exact title is not provided in the sources, it is associated with the manufacture and use of specific pharmaceutical compounds[4].

Foreign Priority and PCT Information

This patent has international implications, with foreign priority and PCT (Patent Cooperation Treaty) information. It was filed under PCT/IB2013/060595 on December 3, 2013, and has corresponding patents in various countries such as Australia, Brazil, Canada, Chile, China, and Cyprus[1].

Scope of the Patent

Subject Matter

The patent covers methods and processes related to the manufacture and use of pharmaceutical compounds. This includes the active ingredients, their formulation, and the processes involved in their production[4].

Claims

The claims of the patent are crucial as they define the scope of protection. While the specific claims are not detailed here, they typically include:

  • Composition of Matter Claims: These claims cover the chemical structure and formulation of the active ingredients.
  • Method of Manufacture Claims: These claims protect the specific processes used to produce the pharmaceutical compounds.
  • Use Claims: These claims cover the intended uses of the pharmaceutical compounds, such as treatment of specific diseases or conditions[3].

Patent Claims Analysis

Claim Coverage Matrix

To understand the full scope of protection, a Claim Coverage Matrix can be used. This matrix categorizes patents by claims and scope concepts, helping to identify which patents and claims are actively protecting the intellectual property. For U.S. Patent 10,023,560, this would involve analyzing each claim to determine its relevance to the technology it intends to protect[3].

Claim Charts

Interactive claim charts generated by software like ClaimScape® can be used to review patent coverage. These charts help technical experts, engineers, scientists, and management to determine whether a particular scope concept is applicable to a target product or method. This tool is essential for identifying gaps in current coverage and highlighting future design opportunities[3].

Patent Landscape

Related Patents

The patent landscape surrounding U.S. Patent 10,023,560 includes other related patents. For example, patents such as U.S. Patent Nos. 9,732,075, 9,790,208, 9,914,720, and 11,124,488 are also related to the active ingredient or the process of its manufacture[4].

Expiration Dates

Understanding the expiration dates of these patents is crucial for strategic planning. The estimated expiration dates for U.S. Patent 10,023,560 and its corresponding foreign patents can be determined by considering the filing dates and the typical patent term of 20 years from the earliest priority date[1][5].

Supplementary Protection Certificates (SPCs)

In some countries, Supplementary Protection Certificates (SPCs) can extend the patent term beyond the standard 20 years. For U.S. Patent 10,023,560, it is important to check if SPCs have been granted in countries like Australia, Brazil, Canada, and others to extend the protection period[1].

Patent Eligibility and Legal Considerations

Section 101 of the U.S. Patent Act

The patentability of processes and methods under U.S. Patent 10,023,560 must comply with Section 101 of the U.S. Patent Act. This section requires that the claims must not be directed to laws of nature, natural phenomena, or abstract ideas. Instead, they must be an application of these principles to a known structure or process[2].

Machine-or-Transformation Test

The machine-or-transformation test is a key criterion for determining patent eligibility. The claims must either be tied to a particular machine or apparatus or transform a particular article into a different state or thing. This test helps ensure that the patent claims are not too broad or abstract[2].

Strategic Implications

Identifying Gaps and Opportunities

Using patent analytics tools, companies can identify gaps in their current patent coverage and highlight future design opportunities. This is particularly important for pharmaceutical companies that need to protect their intellectual property while also innovating and expanding their product lines[3].

Managing Patent Portfolios

Effective management of patent portfolios involves regularly reviewing and updating claim charts and coverage matrices. This helps in maintaining high-value patents, identifying medium-value patents with potential future directions, and deciding which low-value patents may not be worth maintaining[3].

Industry Impact

Competitive Advantage

Holding a patent like U.S. Patent 10,023,560 provides a significant competitive advantage in the pharmaceutical industry. It allows the patent holder to exclude others from making, using, or selling the protected compounds, thereby protecting market share and revenue[4].

Innovation and Research

Patents like this one also drive innovation by incentivizing research and development. By protecting intellectual property, companies are more likely to invest in R&D, leading to the development of new treatments and therapies[3].

Key Takeaways

  • Scope and Claims: U.S. Patent 10,023,560 covers specific pharmaceutical compounds, their manufacture, and use.
  • International Protection: The patent has corresponding protections in multiple countries.
  • Patent Analytics: Tools like Claim Coverage Matrix and claim charts are essential for understanding and managing patent portfolios.
  • Legal Considerations: The patent must comply with Section 101 of the U.S. Patent Act and the machine-or-transformation test.
  • Strategic Implications: Effective patent management is crucial for identifying gaps, opportunities, and maintaining a competitive advantage.

FAQs

What is the significance of U.S. Patent 10,023,560 in the pharmaceutical industry?

U.S. Patent 10,023,560 is significant because it protects specific pharmaceutical compounds, their manufacture, and use, providing a competitive advantage and driving innovation in the industry.

How do claim charts help in managing patent portfolios?

Claim charts help in reviewing patent coverage, identifying gaps in current protection, and highlighting future design opportunities. They make it easier for technical experts and management to understand the scope of protection.

What is the machine-or-transformation test, and why is it important?

The machine-or-transformation test is a criterion for determining patent eligibility. It ensures that patent claims are tied to a particular machine or apparatus or transform a particular article into a different state or thing, preventing overly broad or abstract claims.

How do Supplementary Protection Certificates (SPCs) affect patent protection?

SPCs can extend the patent term beyond the standard 20 years in certain countries, providing additional protection for the patent holder.

Why is it important to analyze the expiration dates of related patents?

Analyzing expiration dates helps companies plan strategically, understand when generic entry may occur, and make informed decisions about their product lifecycle and intellectual property strategy.

Sources

  1. DrugPatentWatch - Details for Patent: 10023560
  2. CAFC - Prometheus Laboratories, Inc. v. Mayo Collaborative Services
  3. SLWIP - Patent Analytics
  4. Idorsia - Patent Marking
  5. PharmaCompass - US Patent 10023560

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,023,560

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Idorsia QUVIVIQ daridorexant hydrochloride TABLET;ORAL 214985-001 Apr 7, 2022 RX Yes No 10,023,560 ⤷  Subscribe TREATMENT OF INSOMNIA ⤷  Subscribe
Idorsia QUVIVIQ daridorexant hydrochloride TABLET;ORAL 214985-002 Apr 7, 2022 RX Yes Yes 10,023,560 ⤷  Subscribe TREATMENT OF INSOMNIA ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,023,560

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
PCT/IB2013/060595Dec 3, 2013

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.